ATNX News and Press, Athenex Inc. From 05/07/21

Image source: The Motley Fool. Athenex, Inc. (NASDAQ: ATNX) Q1 2021 Earnings Call May 7, 2021 , 8:00 p.m. ET Operator Continue reading For further details see: Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript

ChemoCentryx (CCXI) -49% after FDA panel split 9-9 on efficacy for Chemocentryx's vasculitis candidate avacopan and reports outcome of FDA’s expert panel meeting on avacopan.Orphazyme  (ORPH) -28% after arimoclomol flunks late-stage amyotrophic lateral sclerosi...

Athenex (ATNX): Q1 GAAP EPS of -$0.27 beats by $0.13.Revenue of $41.03M (-12.6% Y/Y) beats by $16.49M.As of March 31, 2021, the Company had cash and cash equivalents of $48.0 million, restricted cash of $16.5 million, and short-term investments of $123.2 million.In terms of product sales guid...

Plan to Request Type A Meeting with the FDA for Oral Paclitaxel by the End of May Klisyri® Launched in the U.S. in February 2021 Acquired Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform in May 2021 Management to Host Con...

Shares of Athenex (NASDAQ: ATNX) soared on Wednesday after the pharmaceutical company announced a game-changing merger. By the close of trading, Athenex's stock price was up 22.6% after rising as much as 55% earlier in the day. Athenex reached a deal to buy Kuur Therapeutics...

Gainers: Regional Health Properties (RHE) +124%.SunLink Health Systems (SSY) +66%.Nemaura Medical (NMRD) +60%.Chiasma (CHMA) +48%.Athenex (ATNX) +31%.Caesarstone (CSTE) +30%.Hayward (HAYW) +28%.Altisource Portfolio Solutions (ASPS) +26%.Big 5 Sporting Goods (BGFV) +26%.American...

Gainers: Regional Health Properties (RHE) +71%, Chiasma CHMA +45%, Nemaura Medical (NMRD) +35%, Athenex (ATNX) +40%, iBio (IBIO) +29%.Losers: Cocrystal Pharma COCP -32%, Esperion Therapeutics ESPR -26%, Adamis Pharmaceuticals (ADMP) ...

Chiasma (CHMA) +39% on Q1 results.Athenex (ATNX) +31% on Kuur Therapeutics acquisition.Ault Global Holdings (DPW) +30% on preliminary Q1 results.iBio (IBIO) +26% after resolving Fraunhofer USA lawsuitBig 5 Sporting Goods Corporation (BGFV) +22% on Q1 results.DAVIDsTEA...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the halfway point of the week, investors! Here at InvestorPlace , we’re starting the day off like we always do with a look at the biggest pre-market stock movers. Join us as we list out t...

Clinical stage biopharmaceutical company Athenex (ATNX) has acquired immunotherapy developer Kuur Therapeutics in a deal valued at $185M, in a bid to bolster its cell therapy portfolio.The deal includes an upfront payment of $70M and potential milestone payments of up to $...